Aprogen

Aprogen is a leading biopharmaceutical company dedicated to the research, development, and manufacturing of innovative biosimilar products, novel protein drugs, and bispecific antibodies. With a strong commitment to advancing healthcare solutions, Aprogen operates from its primary address at 545, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do 13215, KR, and also at 5, Osongsaengmyeong 5-ro, Cheongju-si, Chungcheongbuk-do 28158, KR.

Aprogen is focused on pioneering advancements in biotechnology, contributing to improved patient outcomes and enhanced therapeutic options. The company leverages cutting-edge research and development capabilities to create high-quality biopharmaceutical products that meet the evolving needs of the healthcare industry. Aprogen’s commitment to innovation and excellence positions it as a key player in the global biopharmaceutical landscape.

Aprogen continues to expand its capabilities and portfolio, solidifying its position as a trusted provider of advanced biopharmaceutical solutions. We invite the management team at Aprogen to enhance your company's presence on our platform by creating a customized and exclusive company showcase and product listing, highlighting your unique strengths and offerings.